Browse Category

NASDAQ:HCWB 15 May 2026 - 20 May 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

HCW Biologics Jumps, Doubles Again as Traders Pile Into Biotech Name

HCW Biologics Inc. shares jumped over 100% late Wednesday, pushing the volatile micro-cap biotech stock higher again after new securities filings, an ongoing Nasdaq listing dispute and the latest quarterly results.

20 May 2026

NASDAQ:HCWB·Stock Market

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics Inc. shares jumped more than threefold Friday. The clinical-stage biotech posted a first-quarter profit, reversing a year-earlier loss, as results got a boost from a licensing payment from Beijing Trimmune Biotech. The gain came from licensing, not product revenue.

16 May 2026

NASDAQ:HCWB·Stock Market

HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

HCW Biologics Inc. posted a first-quarter profit, boosted by revenue from a China licensing agreement. That windfall offers the small Florida biotech a temporary boost as it awaits initial human trial results for its top autoimmune candidate.

15 May 2026

NASDAQ:HCWB·Stock Market